By binding with microglial receptors such as Triggering Receptor Expressed on Myeloid cells 2 (TREM2), a major AD risk factor, DAP12 triggers various cellular processes such as phagocytosis, proliferation, and the regulation of inflammatory cytokines6,7,8. This evidence concerns the gene TREM2 and Alzheimer disease.